We are live on ! Find out more
CC

Callan Capital Portfolio holdings

AUM $1.35B
1-Year Est. Return 8.35%
This Fund
S&P 500
This Quarter Est. Return
-20.97%
1 Year Est. Return
+8.35%
3 Year Est. Return
+20.11%
5 Year Est. Return
+98.58%
10 Year Est. Return
+95.87%
AUM
$184M
AUM Growth
-$292M
Cap. Flow
-$238M
Cap. Flow %
-129.38%
Top 10 Hldgs %
72.16%
Holding
80
New
10
Increased
15
Reduced
25
Closed
17

Top Buys

Rank Stock Value
1
IBRX icon
ImmunityBio
IBRX
+$79.3M
2
SCHZ icon
Schwab US Aggregate Bond ETF
SCHZ
+$4.15M
3
SCHB icon
Schwab US Broad Market ETF
SCHB
+$3.16M
4
SCHF icon
Schwab International Equity ETF
SCHF
+$2.41M
5
RMD icon
ResMed
RMD
+$1.6M

Top Sells

Rank Stock Value
1
RCPT
RECEPTOS INC COM STK (DE)
RCPT
+$160M
2
SDY icon
State Street SPDR S&P Dividend ETF
SDY
+$47M
3
VGK icon
Vanguard FTSE Europe ETF
VGK
+$25.8M
4
FTGC icon
First Trust Global Tactical Commodity Strategy Fund
FTGC
+$18.7M
5
DBEF icon
Xtrackers MSCI EAFE Hedged Equity ETF
DBEF
+$18.5M

Sector Composition

Rank Sector Weight
1 Miscellaneous 71.2%
2 Healthcare 26.49%
3 Real Estate 1.23%
4 Materials 0.28%
5 Financials 0.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCPT
76
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
– –
-841,101
Closed -$160M
ZGNX
77
DELISTED
Zogenix, Inc.
ZGNX
– –
-1,250
Closed -$17K
AXJL
78
DELISTED
WisdomTree Asia-Pacific ex-Japan Fund
AXJL
– –
-12,842
Closed -$844K
IMUC
79
DELISTED
ImmunoCellular Therapeutics, Ltd.
IMUC
– –
-7,598
Closed -$143K
1 2 3
4

Similar funds

MBA
Maple-Brown Abbott Barangaroo, Australia $1.47B AUM 27.26% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
AP
Adero Partners Pleasanton, California $1.53B AUM 5.52% 1-Year Est. Return
MW
Marcum Wealth Cleveland, Ohio $1.16B AUM 6.7% 1-Year Est. Return
SBIA
Sheaff Brock Investment Advisors Indianapolis, Indiana $1.09B AUM 14.4% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return
TW
Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return
PAME
Parvus Asset Management Europe London, United Kingdom $1.67B AUM

Callan Capital's Q3 2015 Portfolio in Review

As of Q3 2015, Callan Capital held 80 positions worth $184M, down 61% from $477M the previous quarter. Its ten largest holdings account for 72% of the portfolio.

Callan Capital withdrew a net $238M in Q3 2015, closing 17 positions and reducing 25 holdings. Its most notable exit was RECEPTOS INC COM STK (DE), an estimated $160M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 71% of assets, down from 97% a quarter earlier, followed by Healthcare and Real Estate.

Against the trend, Callan Capital opened a new position in ImmunityBio worth $41.6M.

  • Callan Capital's largest Q3 2015 buy was ImmunityBio: 3,632,461 shares worth $41.6M.
  • Callan Capital added most to Vanguard Energy ETF in Q3 2015, an estimated $1.03M increase.
  • Callan Capital's biggest Q3 2015 reduction was Vanguard FTSE Europe ETF, cutting an estimated $25.8M.
  • Callan Capital fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $160M.
  • Callan Capital's ten largest holdings make up 72% of its $184M portfolio in Q3 2015.
  • Callan Capital opened 10 new positions and closed 17 in Q3 2015.
  • Callan Capital's portfolio value fell 61% quarter-over-quarter to $184M.

Based on Callan Capital's 13F filing for Q3 2015, filed 10 Nov 2015.